Seth Harmon

Officer, Viridian Therapeutics, Inc.\DE.

Companies

Viridian Therapeutics, Inc.\DEChief financial officer Mar 4, 2025 to now¹
Viridian Therapeutics, Inc.\DEOfficer Sep 19, 2023 to Nov 13, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Viridian Therapeutics, Inc.\DE VRDN1,711 shares³$33.3K at $19.46Mar 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 3, 2026Shares withheld for tax 2,091 shares at $29.32 of Viridian Therapeutics, Inc.\DE⁴
Mar 3, 2026Shares withheld for tax 2,031 shares at $30.19 of Viridian Therapeutics, Inc.\DE⁵
Mar 3, 2026Exercised options 6,267 shares of Viridian Therapeutics, Inc.\DE⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViridian Therapeutics, Inc.\DE, Chief financial officer
2
SEC EDGARViridian Therapeutics, Inc.\DE, Officer
3
SEC EDGARViridian Therapeutics, Inc.\DE shares after the filing of Mar 4, 2026
4
SEC EDGARForm 4 filed Mar 4, 2026
5
SEC EDGARForm 4 filed Mar 9, 2026